• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肢端肥大症患者肱动脉血流介导的血管舒张功能受损。

Impairment in flow-mediated vasodilatation of the brachial artery in acromegaly.

作者信息

Baykan Merih, Erem Cihangir, Gedikli Omer, Hacihasanoglu Arif, Erdogan Turan, Kocak Mustafa, Kaplan Sahin, Korkmaz Levent, Celik Sükrü

机构信息

Department of Cardiology, Division of Endocrinology, Karadeniz Technical University, Trabzon, Turkey.

出版信息

Med Princ Pract. 2009;18(3):228-32. doi: 10.1159/000204355. Epub 2009 Apr 6.

DOI:10.1159/000204355
PMID:19349727
Abstract

OBJECTIVE

The aim of this study was to assess flow-mediated dilatation (FMD) of the brachial artery in patients with acromegaly.

SUBJECTS AND METHODS

We prospectively evaluated 25 patients with acromegaly (14 females, 11 males; aged 42 +/- 12 years; growth hormone (GH) levels 34 +/- 14 ng/ml) and 27 control subjects (15 females, 12 males; aged 45 +/- 8 years; GH levels 3 +/- 1.5 ng/ml). The patients and controls were matched for age, gender, body mass index, cigarette smoking, blood pressure, lipid levels, diabetes mellitus, hypertension, and its duration. Endothelial function, measured as FMD of the brachial artery using ultrasound, was calculated in the 2 groups. The endothelial function was evaluated by assessing 1-min postischemic FMD of the brachial artery.

RESULTS

The FMD was lower in patients with acromegaly (9.97 +/- 3.5%) than in controls (16.1 +/- 3.4%), and the difference was statistically significant (p = 0.0001).

CONCLUSION

Endothelial dysfunction may develop in the preclinical phase of atherosclerosis in patients with acromegaly. Endothelium-dependent FMD may be impaired in acromegalic patients, and measurement of endothelial function may identify high-risk individuals earlier.

摘要

目的

本研究旨在评估肢端肥大症患者肱动脉的血流介导的扩张(FMD)情况。

研究对象与方法

我们前瞻性地评估了25例肢端肥大症患者(14例女性,11例男性;年龄42±12岁;生长激素(GH)水平34±14 ng/ml)和27例对照者(15例女性,12例男性;年龄45±8岁;GH水平3±1.5 ng/ml)。患者和对照者在年龄、性别、体重指数、吸烟情况、血压、血脂水平、糖尿病、高血压及其病程方面进行了匹配。使用超声测量肱动脉的FMD来评估两组的内皮功能。通过评估肱动脉缺血后1分钟的FMD来评价内皮功能。

结果

肢端肥大症患者的FMD(9.97±3.5%)低于对照者(16.1±3.4%),差异具有统计学意义(p = 0.0001)。

结论

肢端肥大症患者在动脉粥样硬化临床前期可能出现内皮功能障碍。肢端肥大症患者的内皮依赖性FMD可能受损,内皮功能测量可更早识别高危个体。

相似文献

1
Impairment in flow-mediated vasodilatation of the brachial artery in acromegaly.肢端肥大症患者肱动脉血流介导的血管舒张功能受损。
Med Princ Pract. 2009;18(3):228-32. doi: 10.1159/000204355. Epub 2009 Apr 6.
2
Impairment of flow-mediated vasodilatation of brachial artery in patients with Cushing's Syndrome.库欣综合征患者肱动脉血流介导的血管舒张功能受损。
Endocrine. 2007 Jun;31(3):300-4. doi: 10.1007/s12020-007-0033-8.
3
Early vascular alterations in acromegaly.肢端肥大症的早期血管改变
J Clin Endocrinol Metab. 2002 Jul;87(7):3174-9. doi: 10.1210/jcem.87.7.8643.
4
Flow-mediated dilation and gender in patients with coronary artery disease: arterial size influences gender differences in flow-mediated dilation.冠状动脉疾病患者的血流介导的血管舒张与性别:动脉大小影响血流介导的血管舒张中的性别差异。
Echocardiography. 2007 Nov;24(10):1051-7. doi: 10.1111/j.1540-8175.2007.00531.x.
5
Endothelial dysfunction precedes atherosclerosis in systemic sclerosis--relevance for prevention of vascular complications.内皮功能障碍在系统性硬化症中先于动脉粥样硬化出现——对预防血管并发症的意义。
Rheumatology (Oxford). 2007 May;46(5):759-62. doi: 10.1093/rheumatology/kel426. Epub 2007 Jan 23.
6
Investigation of early atherosclerotic changes in acromegalic patients.肢端肥大症患者早期动脉粥样硬化变化的研究。
Int J Clin Pract. 2010 Jan;64(1):39-44. doi: 10.1111/j.1742-1241.2008.01750.x. Epub 2008 Apr 16.
7
Decreased regional blood flow in patients with acromegaly.肢端肥大症患者局部血流减少。
Clin Endocrinol (Oxf). 1998 Dec;49(6):725-31. doi: 10.1046/j.1365-2265.1998.00620.x.
8
Non-invasive assessment of endothelial function by brachial artery flow mediated vasodilatation and its association with coronary artery disease: an Indian perspective.通过肱动脉血流介导的血管舒张对内皮功能进行无创评估及其与冠状动脉疾病的关联:印度视角
J Indian Med Assoc. 2004 May;102(5):243-6, 251-2.
9
Flow-mediated vasodilatation of the brachial artery and intima-media thickness of carotid artery in never-treated subjects.未经治疗的受试者肱动脉血流介导的血管舒张和颈动脉内膜中层厚度
Int Angiol. 2006 Sep;25(3):274-9.
10
Endothelium-dependent vasodilation is impaired in healthy offspring of hypertensive parents.高血压患者后代即使身体健康,其血管内皮依赖性舒张功能仍受损。
Indian Heart J. 2011 May-Jun;63(3):255-8.

引用本文的文献

1
Acromegaly: Cardiovascular risk factors, cardiovascular manifestations and early vascular alterations in relation to disease activity.肢端肥大症:与疾病活动度相关的心血管危险因素、心血管表现和早期血管改变。
Indian Heart J. 2021 Jul-Aug;73(4):499-502. doi: 10.1016/j.ihj.2021.05.005. Epub 2021 Jun 16.
2
Acromegaly, inflammation and cardiovascular disease: a review.肢端肥大症、炎症与心血管疾病:综述
Rev Endocr Metab Disord. 2020 Dec;21(4):547-568. doi: 10.1007/s11154-020-09560-x.
3
The Endothelium in Acromegaly.肢端肥大症中的内皮细胞
Front Endocrinol (Lausanne). 2019 Jul 24;10:437. doi: 10.3389/fendo.2019.00437. eCollection 2019.
4
Preclinical markers of atherosclerosis in acromegaly: a systematic review and meta-analysis.肢端肥大症患者动脉粥样硬化的临床前标志物:系统评价和荟萃分析。
Pituitary. 2018 Dec;21(6):653-662. doi: 10.1007/s11102-018-0911-5.
5
Complications of acromegaly: cardiovascular, respiratory and metabolic comorbidities.肢端肥大症的并发症:心血管、呼吸及代谢共病
Pituitary. 2017 Feb;20(1):46-62. doi: 10.1007/s11102-017-0797-7.
6
The risks of overlooking the diagnosis of secreting pituitary adenomas.漏诊分泌性垂体腺瘤的风险。
Orphanet J Rare Dis. 2016 Oct 6;11(1):135. doi: 10.1186/s13023-016-0516-x.
7
Arterial properties in acromegaly: relation to disease activity and associated cardiovascular risk factors.肢端肥大症的动脉特性:与疾病活动及相关心血管危险因素的关系。
Pituitary. 2016 Jun;19(3):322-31. doi: 10.1007/s11102-016-0710-9.
8
Markers of early atherosclerosis, oxidative stress and inflammation in patients with acromegaly.肢端肥大症患者早期动脉粥样硬化、氧化应激和炎症的标志物。
Pituitary. 2015 Oct;18(5):621-9. doi: 10.1007/s11102-014-0621-6.
9
Pioglitazone ameliorates endothelial dysfunction in those with impaired glucose regulation among the first-degree relatives of type 2 diabetes mellitus patients.吡格列酮可改善 2 型糖尿病患者一级亲属中葡萄糖调节受损者的内皮功能障碍。
Med Princ Pract. 2013;22(2):156-60. doi: 10.1159/000341770. Epub 2012 Sep 4.